Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

PD180970

SKU: orb2901466

Description

PD180970 is a highly potent and ATP-competitive p210Bcr-Abl kinase inhibitor, with an IC50 of 5 nM for inhibiting the autophosphorylation of p210Bcr-Abl. PD180970 also inhibits Src and KIT kinase with IC50s of 0.8 nM and 50 nM, respectively. PD180970 indcues apoptosis of K562 leukemic cells, and can be used for chronic myelogenous leukemia research.

Images & Validation

Key Properties

CAS Number287204-45-9
MW429.27
Purity>98% (HPLC)
FormulaC21H15Cl2FN4O
SMILESCc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F
TargetBcr-Abl
SolubilityIn Vitro: DMSO : 100 mg/mL (232.95 mM; Ultrasonic )

Bioactivity

In Vivo
PD180970 (5 mg/kg; intraperitonial injection; daily; for 7 days) mitigates MPTP-induced neuronal loss in mice. PD180970 has the neuroprotective ability in a preclinical mouse model of Parkinson's disease (PD). Animal model: Male C57BL/6J mice (3-4 months old) injected with MPTP. Dosage: 5 mg/kg. Administration: Intraperitonial injection; daily; for 7 days. Result: Decreased number of activated microglia on activation by MPTP in mice brains. And showed significant reduction in intensity of Iba1 expression in activated microglia.
In Vitro
PD180970 (0.5 μM; 24-96 hours) treatment causes cell death K562 cells. PD180970 (0.5 μM; 24-48 hours) treatment induces apoptosis of K562 cells. The result shows increase in annexin V-PI double-positive cells. PD180970 inhibits tyrosine phosphorylation of p210Bcr-Abl, Gab2, and CrkL in K562 cells with IC50 values of 170 nM, 80 nM, and 80 nM, respectively. In vitro, PD180970 potently inhibits autophosphorylation of p210Bcr-Abl (IC50 of 5 nM) and the kinase activity of purified recombinant Abl tyrosine kinase (IC50 of 2.2 nM). The blocking Bcr-Abl kinase activity using PD180970 in the human K562 CML cell line resulted in inhibition of Stat5 DNA-binding activity with an IC50 of 5 nM. Cell Viability Assay Cell line: K562 cells. Concentration: 0.5 μM Incubation time: 24 hours, 48 hours, 72 hours, 96 hours. Result: Resulted in cell death. Apoptosis Analysis Cell line: K562 cells. Concentration: 0.5 μM Incubation time: 24 hours, 48 hours. Result: Increased annexin V-positive/PI-negative cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • PD180970 [orb1704251]

    98.67% (May vary between batches)

    287204-45-9

    429.27

    C21H15Cl2FN4O

    10 mg, 25 mg, 50 mg, 5 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

100 mg
500 mg
5 mg
$ 90.00
10 mg
$ 140.00
25 mg
$ 220.00
50 mg
$ 320.00